Skip to main content

ESTILO DE VIDA EN PRIMER EPISODIO MANIACO Y POTENCIACION FUNCIONAL

PI21/00713

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2021
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOARABA
Execution centre HOSPITAL UNIVERSITARIO ARABA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Emotional intelligence and neurocognition profiles in first-episode psychosis, A two-year follow-up study

  • Clougher, Derek|||0000-0001-7631-3845
  • Forte, Maria Florencia|||0000-0001-5930-5501
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Sánchez Torres, Ana Maria|||0000-0002-9505-2406
  • Serra-Navarro, Maria|||0000-0002-9736-4630
  • Penadés, Rafael|||0000-0002-1564-3717
  • Lobo, Antonio|||0000-0002-9098-655X
  • Pinto, A.G.
  • Panadero, Rocío
  • Roldan-Bejarano, Alexandra|||0000-0001-9905-3943
  • Vieta, Eduard|||0000-0002-0548-0053
  • de la Serna, Elena|||0000-0002-7869-9881
  • Trabsa, Amira|||0000-0002-8669-0676
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • Torrent, Carla|||0000-0003-0335-582X
  • Tortorella, A.
  • Menculini, G.
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Cuesta, M.J.
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Salmerón, Sergi|||0000-0002-0212-4491
  • Arbelo, Néstor|||0000-0002-2630-3259
  • Ferrer-Quintero, Marta|||0000-0002-7935-9424
  • Echevarría, A.
  • Selma, Judit
  • Grasa, Eva|||0000-0003-1100-7489
  • Marin, Julen
  • Mar, Lorea
  • Cámara, Concepción de la|||0000-0003-2284-7862
  • Ruíz-Lázaro, P.M.
  • Nacher, Juan|||0000-0001-7599-3957
  • Cañete Nicolas, Carlos
  • Mané, Anna|||0000-0003-2127-349X
  • Toll, Alba|||0000-0003-2399-5250
  • Solé, Brisa|||0000-0003-1673-8248
  • Mallorquí, Aida|||0000-0003-4038-3045
  • Castro-Fornieles, Josefina|||0000-0003-0632-2687
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • Contreras, Fernando|||0000-0003-2929-2804
  • Sáiz, Pilar A.|||0000-0002-5705-4523
  • Bobes-Bascarán, Maria T.|||0000-0002-5279-504X
  • Segarra, R.
  • Zabala Torres, Alaitz|||0000-0002-3931-4221
  • Scala, Marcello|||0000-0003-2194-7239
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Usall, J.
  • Butjosa Molines, Anna|||0000-0001-5317-9508
  • Pomarol-Clotet, E.
  • García-León, M.Á.
  • Ibañez, A.
  • Moreno-Izco, L.
  • Balanzá-Martínez, Vicent|||0000-0001-7772-7396
Emotional intelligence (EI) and neurocognition (NC) impairments are common in first-episode psychosis (FEP), yet their evolution over time remains unclear. This study identified patient profiles in EI and NC performance in FEP. 98 adult FEP patients and 128 healthy controls (HCs) were tested on clinical, functional, EI, and NC variables at baseline and two-year follow-up (FUP). A repeated-measures ANOVA compared the effects of group (patients and HCs) and time on EI. Significant EI improvements were observed in both groups. Four groups were created based on NC and EI performance at baseline and FUP in patients: impairment in NC and EI, impairment in NC only, impairment in EI only, and no impairment. At FUP, patients impaired in NC and EI showed less cognitive reserve (CR), greater negative and positive symptoms, and poorer functional outcomes. At FUP, three group trajectories were identified: (I) maintain dual impairment (II) maintain no impairment or improve, (III) maintain sole impairment or worsen. The maintain dual impairment group had the lowest levels of CR. EI and NC impairments progress differently in FEP. Greater CR may protect against comorbid EI/NC impairment. Identifying these patient characteristics could contribute to the development of personalised interventions.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Validation of the Spanish Childhood Trauma Questionnaire-Short Form in adolescents with suicide attempts

  • García-Fernández, Ainoa|||0000-0002-4874-0353
  • Martínez-Cao, Clara|||0000-0002-3803-9301
  • Sánchez-Fernández-Quejo, Alberto
  • Bobes-Bascarán, Maria T.|||0000-0002-5279-504X
  • Andreo Jover, Jorge|||0000-0002-6703-8017
  • Ayad-Ahmed, Wala|||0000-0002-0786-0076
  • Cebrià, Ana Isabel|||0000-0002-2632-8130
  • Díaz-Marsá, Marina|||0000-0003-1364-3163
  • Garrido-Torres, Nathalia|||0000-0003-1810-947X
  • Gómez, Sandra
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Grande, Iria|||0000-0002-0137-0666
  • Iglesias Gutiérrez, Noelia|||0000-0002-8684-8082
  • March, Katya B.
  • Palao, Diego|||0000-0002-3323-6568
  • Pérez-Díez, Iván|||0000-0002-9972-2825
  • Roberto Herrero, Natalia|||0000-0002-5391-2711
  • Ruiz-Veguilla, Miguel|||0000-0002-5790-7346
  • Torre-Luque, Alejandro de la|||0000-0003-0595-6127
  • Zorrilla, Iñaki|||0000-0001-6444-8208
  • Pérez Solà, Víctor|||0000-0002-5825-2337
  • Sáiz, Pilar A.|||0000-0002-5705-4523
  • García-Portilla, María Paz|||0000-0003-3643-1622
Child maltreatment is associated with a higher probability of mental disorders and suicidal behavior in adolescence. Therefore, accurate psychometric instruments are essential to assess this. To validate the Spanish version of the Childhood Trauma Questionnaire-Short Form (CTQ-SF) in adolescents with suicide attempts. Multisite cohort study of 208 adolescents with suicide attempts using data from the following scales: Mini International Neuropsychiatric Interview (MINI), Columbia Suicide Severity Rating Scale (C-SSRS), Patient Health Questionnaire (PHQ-9), and CTQ-SF. Statistical analysis: CTQ-SF scores analyzed by descriptive statistics. Internal consistency: McDonald's omega and Cronbach's alpha. Concurrent validity with PHQ-9 and C-SSRS scores: Spearman correlation coefficient. Structural validity: Confirmatory factor analysis. Floor and ceiling effects: Physical abuse and neglect as well as sexual abuse demonstrated high floor effects (50.0, 35.1, and 61.1% of adolescents, respectively). No ceiling effects were found. The CTQ-SF had excellent internal consistency (McDonald's omega = 0.94), as did the majority of its subscales (Cronbach's alpha 0.925-0.831) except for physical neglect (0.624). Its concurrent validity was modest, and the emotional neglect subscale had the lowest Spearman correlation coefficients (0.067-0.244). Confirmatory factor analysis: Compared with alternative factor structures, the original CTQ-SF model (correlated 5-factor) exhibited a better fit [S-B χ 2 = 676.653, p < 0; RMSEA (90% CI = 0.076-0.097) = 0.087; SRMR = 0.078; CFI = 0.980; TLI = 0.978]. The Spanish CTQ-SF is a reliable, valid instrument for assessing traumatic experiences in adolescents at high risk of suicide. It appears appropriate for use in routine clinical practice to monitor maltreatment in this group.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

From Genetics to Psychosocial Functioning, Unraveling the Mediating Roles of Cognitive Reserve, Cognition, and Negative Symptoms in First-Episode Psychosis

  • Forte, Maria Florencia|||0000-0001-5930-5501
  • Clougher, Derek|||0000-0001-7631-3845
  • González-Segura, Àlex|||0000-0002-9398-2183
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Sánchez Torres, Ana Maria|||0000-0002-9505-2406
  • Vieta, Eduard|||0000-0002-0548-0053
  • Garriga, Marina|||0000-0001-7312-4969
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Diaz-Caneja, C.M.
  • Roldan-Bejarano, Alexandra|||0000-0001-9905-3943
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • de la Serna, Elena|||0000-0002-7869-9881
  • Mané, Anna|||0000-0003-2127-349X
  • Mas, Sergi|||0000-0003-3336-6298
  • Torrent, Carla|||0000-0003-0335-582X
  • Allot, K.|||0000-0002-0640-4634
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Pérez, Antonio|||0000-0001-5528-1143
  • Meseguer, A.
  • Cámara, Concepción de la|||0000-0003-2284-7862
  • Ruiz-Lazaro, P.M.
  • Calvo, L.
  • Estébanez, M.J.
  • Ferrer, Marta
  • Echevarría, A.
  • Escarti, M.J.
  • Rivero, O.
  • Trabsa, Amira|||0000-0002-8669-0676
  • Legido, Teresa|||0000-0002-1175-2641
  • Serra, M.
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • Castro Gutiérrez, Jorge
  • Parra, S.M.
  • Santo, F.D.
  • García-Portilla, María Paz
  • Echevarría, R.S.
  • Rabadán, A.Z.
  • Martínez-Gras, I.
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Usall, J.
  • Butjosa Molines, Anna|||0000-0001-5317-9508
  • Clotet, E.P.
  • Salvador, R.
  • Ibañez, Angela|||0000-0003-2751-0150
  • Cuesta, M.J.
  • Balanzá-Martínez, Vicent|||0000-0001-7772-7396
Background: Studies have shown associations between polygenic risk scores for educational attainment (PRS), cognitive reserve (CR), cognition, negative symptoms (NS), and psychosocial functioning in first-episode psychosis (FEP). However, their specific interactions remain unclear. This study aimed to investigate the mediating roles of CR, cognition, and NS in the relationship between PRS and psychosocial functioning one year after a FEP. Additionally, we sought to explore the impact of two NS subtypes on this relationship: diminished Expression (EXP-NS) and Motivation and Pleasure (MAP-NS). Methods: A total of 138 FEP participants, predominantly male (70%), with a mean age of 24.77 years (SD = 5.29), underwent genetic, clinical, and cognitive assessments two months after study enrollment. Functioning evaluation followed at one-year follow-up. To investigate the mediating role of CR, cognition, and NS in the relationship between PRS and functioning, a serial mediation model was employed. Two further mediation models were tested to explore the differential impact of EXP-NS and MAP-NS. Mediation analysis was performed using the PROCESS macro version 4.1 within SPSS version 26. Results: The serial mediation model revealed a causal chain for PRS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Validation of the virtual reality functional capacity assessment tool (VRFCAT) in a Spanish sample of individuals with psychosis and healthy controls

  • González-Blanch, César|||0000-0002-3181-4731
  • López-Carrilero, Raquel|||0000-0003-4110-794X
  • Bobes-Bascarán, Maria T.|||0000-0002-5279-504X
  • Catalan, Ana|||0000-0002-0418-7904
  • Aymerich, Claudia|||0000-0003-0040-1608
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Gutiérrez-Zotes, Alfonso|||0000-0002-4858-1487
  • Díaz-Mandado, Olimpia
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Cano-Escalera, Guillermo
  • Zubia, Marta
  • Guinart, Daniel
  • del-Castillo-Serrano, Manuel
  • Vilella, Elisabet|||0000-0002-1887-5919
  • García-Álvarez, Leticia
  • Ochoa, Susana|||0000-0001-6792-1080
  • Correa-Ghisays, Patricia|||0000-0002-1752-7349
  • Balanzá-Martínez, Vicent|||0000-0001-7772-7396
  • Vicent Sánchez-Ortí, Joan|||0000-0002-8209-6688
  • Pousa Tomàs, Esther|||0000-0003-4423-6739
  • Miret, Salvador|||0000-0002-2275-8272
  • Falip, Cristina
  • Reguera-Pozuelo, Pablo
  • Fernández-Martínez, Rafael|||0000-0002-0842-898X
  • García-Cabeza, Ignacio|||0000-0002-7542-4321
  • Campos-Rodriguez, Carlos|||0000-0002-6982-1339
  • Crosas Armengol, Josep Maria|||0000-0002-0734-2957
  • Cobo Gomez, Jesus Vicente|||0000-0002-2032-9343
  • Pardina-Torner, Helena|||0000-0002-0720-3412
  • Perona-Garcelán, Salvador|||0000-0002-7771-7857
  • Muñoz-Caracuel, Manuel|||0000-0003-1667-5646
  • Yorca-Ruiz, Ángel|||0000-0002-2701-3755
  • Ortiz García de la Foz, Víctor|||0000-0002-0627-1827
  • Ayesa-Arriola, Rosa|||0000-0003-0570-5352
The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) is a performance-based measure developed to assess functional capacity through simulations of daily activities. This study examined its psychometric properties in a Spanish sample, including individuals with first-episode psychosis (FEP), schizophrenia, and healthy controls. A total of 370 participants (99 FEP, 116 schizophrenia, and 155 controls) completed the VRFCAT in a multicenter study. Internal consistency (McDonald's omega), discriminative validity (group comparisons and ROC curves), and convergent validity via correlations with cognitive performance and clinical symptoms were examined. Reference percentiles were calculated from the healthy control sample using quantile regression, stratified by age and education. Item-level VRFCAT completion times showed acceptable to good internal consistency overall and in controls and schizophrenia samples, but poor in FEP. Differences in VRFCAT performance emerged (χ 2 = 108.88, p.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Validation of the virtual reality functional capacity assessment tool (VRFCAT) in a Spanish sample of individuals with psychosis and healthy controls

  • González-Blanch, César
  • López-Carrilero, Raquel
  • Bobes-Bascarán, Teresa
  • Catalán, Ana
  • Aymerich, Claudia
  • Rodriguez-Jimenez, Roberto
  • Gutiérrez-Zotes, Alfonso
  • Díaz-Mandado, Olimpia
  • González-Pinto, Ana
  • Cano-Escalera, Guillermo
  • Zubia, Marta
  • Guinart, Daniel
  • Del-Castillo-Serrano, Manuel
  • Vilella, Elisabet
  • García-Álvarez, Leticia
  • Ochoa, Susana
  • Correa-Ghisays, Patricia
  • Balanzá-Martínez, Vicent
  • Sánchez-Ortí, Joan Vicent
  • Pousa, Esther
  • Miret, Salvador
  • Falip, Cristina
  • Reguera-Pozuelo, Pablo
  • Fernández-Martínez, Rafael
  • García-Cabeza, Ignacio
  • Campos-Rodriguez, Carlos
  • Crosas, Josep Maria
  • Cobo, Jesus
  • Pardina-Torner, Helena
  • Perona-Garcelán, Salvador
  • Muñoz-Caracuel, Manuel
  • Yorca-Ruiz, Ángel
  • Ortiz-García de la Foz, Víctor
  • Ayesa-Arriola, Rosa
Background The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) is a performance-based measure developed to assess functional capacity through simulations of daily activities. This study examined its psychometric properties in a Spanish sample, including individuals with first-episode psychosis (FEP), schizophrenia, and healthy controls. Methods A total of 370 participants (99 FEP, 116 schizophrenia, and 155 controls) completed the VRFCAT in a multicenter study. Internal consistency (McDonald’s omega), discriminative validity (group comparisons and ROC curves), and convergent validity via correlations with cognitive performance and clinical symptoms were examined. Reference percentiles were calculated from the healthy control sample using quantile regression, stratified by age and education. Results Item-level VRFCAT completion times showed acceptable to good internal consistency overall and in controls and schizophrenia samples, but poor in FEP. Differences in VRFCAT performance emerged (χ2 = 108.88, p < .001), with controls performing best, schizophrenia worst, and FEP in between. ROC analyses indicated good discriminative accuracy in distinguishing patients from controls (area under the curve [AUC] = 0.779, sensitivity = 80.0%, specificity = 64.2%); but limited discrimination between schizophrenia and FEP. Age and education, but not sex, significantly affected performance. VRFCAT showed small-to-moderate correlations with cognitive performance, and no significant associations with symptom severity. Conclusions The VRFCAT is a reliable and valid tool for assessing functional capacity in Spanish-speaking individuals with psychotic disorders. Its ecological validity, objectivity, psychometric properties, brief administration time, and ease of use support its potential use in clinical and research settings for evaluating functional recovery and treatment outcomes., This study was supported by the Instituto de Salud Carlos III (ISCIII) through project PI20/00066, co-funded by the European Union. Ana González-Pinto acknowledges the support of the Spanish Ministry of Science, Innovation and Universities, integrated into the National R&D&I Plan and co-funded by the ISCIII–Subdirección General de Evaluación and the European Regional Development Fund (FEDER; grants PI18/01055 and PI21/00713), as well as the CIBERSAM, the Basque Government (grant 2022111054), and the University of the Basque Country (grant IT1631–22). Roberto Rodriguez-Jimenez is partially supported by the Madrid Regional Government (R&D activities in Biomedicine S2022/BMD–7216 (AGES 3–CM)), and CIBERSAM-ISCIII. Ángel Yorca-Ruiz is funded by a predoctoral contract (PFIS FI/00162) from the Carlos III Health Institute. Rosa Ayesa-Arriola was funded by a Miguel Servet contract from the Carlos III Health Institute (CP18/00003) and a Consolidator Grant from the Spanish Ministry of Science and Innovation (CNS2022–136110).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Clinical predictors and psychosocial risk factors of suicide attempt severity

  • González-Ortega, Itxaso
  • Díaz-Marsá, Marina
  • Lopez-Peña, Purificación
  • Fernández-Sevillano, Jessica
  • Andreo-Jover, Jorge
  • Bobes, Julio
  • Bravo-Ortiz, M.
  • Cebriá, Ana Isabel
  • Crespo-Facorro, Benedicto
  • Torre-Luque, Alejandro de la
  • Elices, Matilde
  • Fernández-Rodrigues, Verónica
  • Garrido-Torres, Nathalia
  • Grande, Iria
  • Palao-Tarrero, Ángela
  • Pemau, Andrés
  • Roberto, Natalia
  • Ruiz‐Veguilla, Miguel
  • Seijo-Zazo, Elisa
  • Alberich, Susana
  • González-Pinto, Ana
  • Pérez, Víctor
[Background] Suicide attempts are an important predictor of completed suicide and may differ in terms of severity of medical consequences or medical lethality. There is little evidence on serious suicide attempt (SSA) and very few studies have compared SSA with non-SSA., [Objective] The aim of this multisite, coordinated, cohort study was to analyze the role of clinical variables and the sociodemographic and psychological risk factors of SSA., [Method] In this multisite, coordinated, cohort study, 684 participants (222 for the mild suicide attempt group, 371 for the moderate suicide attempt group and 91 for the SSA group) were included in the study. Ordinal regression models were performed to analyze the predictor variables of SSA., [Results] Early physical abuse (OR = 1.231) and impulsivity (OR = 1.036) were predictors of SSA, while depressive symptoms were associated with a lower risk of SSA., [Conclusion] Environmental and psychological factors as physical abuse and impulsivity are related with severe suicide severity. These findings will help to develop strategies to prevent suicide and may be considered for the treatment and management of suicide., This study was funded by the Spanish Ministry of Economy and Competitiveness through the Carlos III Health Institute (ISCIII) and the European Regional Development Fund (ERDF): Complutense University of Madrid (PI20/00259), Mar Institute of Medical Research (IMIM), Parc de Salut Mar (PI19/00236), University of Oviedo (PI19/01027), Hospital Clínico San Carlos (PI19/01256), Araba University Hospital (PI19/00569), La Paz Institute for Health Research (IdiPAZ) (PI19/00941), Hospital Universitari Parc Taulí (PI19/01484), Hospital Clínic of Barcelona (PI19/000954), Hospital Virgen del Rocío (PI19/00685). Dr. Bobes has received partial support from the Government of the Principality of Asturias PCTI-2021-2023 IDI/2021/111, the Fundación para la Investigación e Innovación Biosanitaria del Principado de Asturias (FINBA), and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, and Ministerio de Ciencia e Innovación. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. González-Pinto thanks the support of the Spanish Ministry of Economy and Competitiveness through the Carlos III Health Institute (ISCIII) and the European Regional Development Fund (ERDF) (PI18/01055, PI21/00713); the Foundation for Health Innovation and Research (BIOEF); the Networking Centre for Biomedical Research in Mental Health (CIBERSAM), the Basque Government [grant number 2017111104] and the University of the Basque Country [grant number 321218ELCY]. The psychiatric research department in Araba University Hospital is supported by the Stanley Research Foundation [grant number 03-RC-003]. Dr. Grande thanks the support of the Spanish Ministry of Science and Innovation (MCIN) (PI19/00954) integrated into the Plan Nacional de I + D + I and cofinanced by the ISCIII-Subdirección General de Evaluación y Fondos Europeos de la Unión Europea (FEDER, FSE, Next Generation EU/Plan de Recuperación Transformación y Resiliencia_PRTR); the Instituto de Salud Carlos III; the Networking Centre for Biomedical Research in Mental Health (CIBERSAM); and the Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement (2017 SGR 1365), CERCA Programme/Generalitat de Catalunya as well as the Fundació Clínic per la Recerca Biomèdica (Pons Bartran 2022-FRCB_PB1_2022)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Validation of the virtual reality functional capacity assessment tool (VRFCAT) in a Spanish sample of individuals with psychosis and healthy controls

  • González-Blanch, César
  • López-Carrilero, Raquel
  • Bobes-Bascarán, Teresa
  • Catalán, Ana
  • Aymerich, Claudia
  • Rodríguez-Jiménez, Roberto
  • Gutiérrez-Zotes, Alfonso
  • Díaz-Mandado, Olimpia
  • González-Pinto, Ana
  • Cano-Escalera, Guillermo
  • Zubia, Marta
  • Guinart, Daniel
  • Del-Castillo-Serrano, Manuel
  • Vilella, Elisabet
  • García-Álvarez, Leticia
  • Ochoa, Susana
  • Correa-Ghisays, Patricia
  • Balanzá-Martínez, Vicent
  • Sánchez-Ortí, Joan Vicent
  • Pousa, Esther
  • Miret, Salvador
  • Falip, Cristina
  • Reguera-Pozuelo, Pablo
  • Fernández-Martínez, Rafael
  • García-Cabeza, Ignacio
  • Campos-Rodriguez, Carlos
  • Crosas, Josep Maria
  • Cobo, Jesús
  • Pardina-Torner, Helena
  • Perona-Garcelán, Salvador
  • Muñoz-Caracuel, Manuel
  • Yorca-Ruiz, Ángel
  • Ortiz-Garcia de la Foz, Victor
  • Ayesa Arriola, Rosa
[Background] The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) is a performance-based measure developed to assess functional capacity through simulations of daily activities. This study examined its psychometric properties in a Spanish sample, including individuals with first-episode psychosis (FEP), schizophrenia, and healthy controls., [Methods] A total of 370 participants (99 FEP, 116 schizophrenia, and 155 controls) completed the VRFCAT in a multicenter study. Internal consistency (McDonald’s omega), discriminative validity (group comparisons and ROC curves), and convergent validity via correlations with cognitive performance and clinical symptoms were examined. Reference percentiles were calculated from the healthy control sample using quantile regression, stratified by age and education., [Results] Item-level VRFCAT completion times showed acceptable to good internal consistency overall and in controls and schizophrenia samples, but poor in FEP. Differences in VRFCAT performance emerged (χ2 = 108.88, p < .001), with controls performing best, schizophrenia worst, and FEP in between. ROC analyses indicated good discriminative accuracy in distinguishing patients from controls (area under the curve [AUC] = 0.779, sensitivity = 80.0%, specificity = 64.2%); but limited discrimination between schizophrenia and FEP. Age and education, but not sex, significantly affected performance. VRFCAT showed small-to-moderate correlations with cognitive performance, and no significant associations with symptom severity., [Conclusions] The VRFCAT is a reliable and valid tool for assessing functional capacity in Spanish-speaking individuals with psychotic disorders. Its ecological validity, objectivity, psychometric properties, brief administration time, and ease of use support its potential use in clinical and research settings for evaluating functional recovery and treatment outcomes., This study was supported by the Instituto de Salud Carlos III (ISCIII) through project PI20/00066, co-funded by the European Union. Ana González-Pinto acknowledges the support of the Spanish Ministry of Science, Innovation and Universities, integrated into the National R&D&I Plan and co-funded by the ISCIII–Subdirección General de Evaluación and the European Regional Development Fund (FEDER; grants PI18/01055 and PI21/00713), as well as the CIBERSAM, the Basque Government (grant 2022111054), and the University of the Basque Country (grant IT1631–22). Roberto Rodriguez-Jimenez is partially supported by the Madrid Regional Government (R&D activities in Biomedicine S2022/BMD–7216 (AGES 3–CM)), and CIBERSAM-ISCIII. Ángel Yorca-Ruiz is funded by a predoctoral contract (PFIS FI/00162) from the Carlos III Health Institute. Rosa Ayesa-Arriola was funded by a Miguel Servet contract from the Carlos III Health Institute (CP18/00003) and a Consolidator Grant from the Spanish Ministry of Science and Innovation (CNS2022–136110)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis

  • Solanes, Aleix
  • Mezquida, Gisela
  • Janssen, Joost
  • Amoretti, Silvia
  • Lobo, Antonio
  • González-Pinto, Ana
  • Arango, Celso
  • Vieta, Eduard
  • Castro-Fornieles, Josefina
  • Bergé, Daniel
  • Albacete, Auria
  • Giné, Eloi
  • Parellada, Mara
  • Bernardo, Miguel
  • Bioque, Miquel
  • Morén, Constanza
  • Pina-Camacho, Laura
  • Díaz-Caneja, Covadonga M.
  • Zorrilla, Iñaki
  • Corres, Edurne Garcia
  • De-La-Camara, Concepción
  • Barcones, Fe
  • Escarti, María José
  • Aguilar, Eduardo Jesus
  • Legido, Teresa
  • Martin, Marta
  • Verdolini, Norma
  • Martinez-Aran, Anabel
  • Baeza, Immaculada
  • de la Serna, Elena
  • Contreras, Fernando
  • Bobes, Julio
  • García-Portilla, María Paz
  • Sanchez-Pastor, Luis
  • Rodriguez-Jimenez, Roberto
  • Usall, Judith
  • Butjosa, Anna
  • Salgado-Pineda, Pilar
  • Salvador, Raymond
  • Pomarol-Clotet, Edith
  • Radua, Joaquim
Detecting patients at high relapse risk after the first episode of psychosis (HRR-FEP) could help the clinician adjust the preventive treatment. To develop a tool to detect patients at HRR using their baseline clinical and structural MRI, we followed 227 patients with FEP for 18–24 months and applied MRIPredict. We previously optimized the MRI-based machine-learning parameters (combining unmodulated and modulated gray and white matter and using voxel-based ensemble) in two independent datasets. Patients estimated to be at HRR-FEP showed a substantially increased risk of relapse (hazard ratio = 4.58, P < 0.05). Accuracy was poorer when we only used clinical or MRI data. We thus show the potential of combining clinical and MRI data to detect which individuals are more likely to relapse, who may benefit from increased frequency of visits, and which are unlikely, who may be currently receiving unnecessary prophylactic treatments. We also provide an updated version of the MRIPredict software.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The role of cognitive reserve and clinical symptoms in the association between genetic liability for educational attainment and functioning in first-episode psychosis: a mediation analysis

  • Clougher, Derek
  • G Segura, Àlex
  • Forte, María Florencia
  • Mezquida, Gisela
  • Cuesta, Manuel J.
  • Vieta, Eduard
  • Amoretti, Silvia
  • Lobo, Antonio
  • González-Pinto, Ana
  • M. Díaz-Caneja, Covadonga
  • Roldán, Alexandra
  • Fico, Giovanna
  • de la Serna, Elena
  • Bergé, Daniel
  • Gassó, Patricia
  • Rodriguez, Natalia
  • Verdolini, Norma
  • Tortorella, Alfonso
  • Menculini, Giulia
  • Ribasés, Marta
  • Bernardo, Miguel
  • Mas, Sergi
Background: Polygenic risk scores for educational attainment (PRSEA), cognitive reserve (CR), and clinical symptoms are associated with psychosocial functioning in first-episode psychosis (FEP). Nevertheless, the mechanisms underlying their complex interaction is yet to be explored. This study aimed to assess the mediating role of CR and clinical symptoms, both negative (NS) and positive (PS), on the interrelationship between PRSEA and functionality, one year after a FEP. Methods: A total of 162 FEP patients underwent clinical, functional, and genetic assessments. Using genome-wide association study (GWAS) summary results, PRSEA were constructed for each individual. Two mediation models were explored. The parallel mediation model explored the relationship of PRSEA with functionality through CR and clinical symptoms, NS, and PS. The serial mediation model tested a causal chain of the three mediators: CR, NS and PS. Mediation analysis was performed using the PROCESS function V.4.1 in SPSS V.22. Results: A serial mediation model revealed a causal chain for PRSEA > CR > NS > Functionality (β=-0.35, 95%CI [-0.85, -0.04], p<0.05). The model fit the data satisfactorily (CFI=1.00; RMSEA=0.00; SRMR=7.2x10-7). Conversely, in a parallel mediation, none of the three mediators significantly mediated the relationship between PRSEA and functionality and the model poorly fit the data (CFI=0.30; RMSEA=0.25; SRMR=0.11). Conclusions: Both CR and NS mediate the relationship between PRSEA and functionality at oneyear follow-up, using serial mediation analysis. This may be relevant for prevention and personalized early intervention to reduce illness impact and improve functional outcomes in FEP patients.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study

  • Clougher, Derek
  • Forte, María Florencia
  • Mezquida, Gisela
  • Sánchez-Torres, Ana M.
  • Serra-Navarro, María
  • Penadés, Rafael
  • Lobo, Antonio
  • González Pinto, Ana
  • Panadero, Rocío
  • Roldán, Alexandra
  • Vieta, Eduard
  • de la Serna, Elena
  • Trabsa, Amira
  • Martínez-Arán, Anabel
  • Torrent, Carla
  • Tortorella, Alfonso
  • Menculini, Giulia
  • Ramos-Quiroga, Josep Antoni
  • Cuesta, Manuel J.
  • Bernardo, Miquel
  • Amoretti, Silvia
  • Salmerón, Sergi
  • Arbelo, Néstor
  • Ferrer-Quintero, Marta
  • Echevarría, Ana
  • Selma, Judit
  • Grasa, Eva Ma
  • Marin, Julen
  • Mar, Lorea
  • De la Cámara, Concepción
  • Ruíz-Lázaro, Pedro M
  • Nacher, Juan
  • Nicolas, Carlos Cañete
  • Mané, Anna
  • Toll, Alba
  • Solé, Brisa
  • Mallorqui, Aida
  • Castro-Fornieles, Josefina
  • Baeza, Inmaculada
  • Contreras, Fernando
  • Sáiz, Pilar A.
  • Bobes-Bascarán, Teresa
  • Segarra, Rafael
  • Zabala, Arantzazu
  • Scala, Mauro
  • Rodriguez-Jimenez, Roberto
  • Usall, Judith
  • Butjosa, Anna
  • Pomarol-Clotet, Edith
  • García-León, Maria Ángeles
  • Ibañez, Angela
  • Moreno-Izco, Lucía
  • Balanzá-Martínez, Vicent
Emotional intelligence (EI) and neurocognition (NC) impairments are common in first-episode psychosis (FEP), yet their evolution over time remains unclear. This study identified patient profiles in EI and NC performance in FEP. 98 adult FEP patients and 128 healthy controls (HCs) were tested on clinical, functional, EI, and NC variables at baseline and two-year follow-up (FUP). A repeated-measures ANOVA compared the effects of group (patients and HCs) and time on EI. Significant EI improvements were observed in both groups. Four groups were created based on NC and EI performance at baseline and FUP in patients: impairment in NC and EI, impairment in NC only, impairment in EI only, and no impairment. At FUP, patients impaired in NC and EI showed less cognitive reserve (CR), greater negative and positive symptoms, and poorer functional outcomes. At FUP, three group trajectories were identified: (I) maintain dual impairment (II) maintain no impairment or improve, (III) maintain sole impairment or worsen. The maintain dual impairment group had the lowest levels of CR. EI and NC impairments progress differently in FEP. Greater CR may protect against comorbid EI/NC impairment. Identifying these patient characteristics could contribute to the development of personalised interventions.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Impact of relapse in BDNF receptors expression in patients with a first episode of schizophrenia

  • Bioque, Miquel
  • Llorca-Bofí, Vicent
  • MacDowell, Karina S
  • Amoretti, Sílvia
  • Mezquida, Gisela
  • Cuesta, Manuel J.
  • Díaz-Caneja, Covadonga M.
  • Ibáñez, Ángela
  • Segarra, Rafael
  • González-Pinto, Ana
  • Roldán, Alexandra
  • Sáiz, Pilar A.
  • Mané, Anna
  • Lobo, Antonio
  • Martínez-Pinteño, Albert
  • Cano-Escalera, Guillermo
  • Berrocoso, Esther
  • Bernardo, Miquel
  • 2EPs Group
Background and Hypothesis Relapsing after a first episode of schizophrenia (FES) is a main predictor of clinical and functional prognosis. Brain-derived neurotrophic factor (BDNF) plays a critical role in neuronal development and plasticity, and its signaling may be altered by successive relapses. Design We assessed the impact of first relapse in the expression of the 2 isoforms of the BDNF tropomyosin-related kinase B (TrkB) receptor (active full-length TrkB-F and inactive truncated TrkB-T) in peripheral blood mononuclear cells from 53 FES patients in clinical remission followed up for 3 years. Results The group of participants that relapsed (n = 24) during the follow-up presented a significant decrease in the expression of the active TrkB-F receptor compared to baseline (M = 100 ± 28.13 vs. M = 83.42 ± 33.84, t = 2.5, P = .02), with no changes in the inactive TrkB-T receptor expression nor in BDNF plasma levels. This decrease also led to a significant decline in the F/T ratio (M = 1.13 ± 0.38 vs. 0.94 ± 0.36, t = 2.17, P = .041). No significant differences were found in the receptors’ expression nor in plasma levels in the group of cases that remained in remission (n = 29). These results were not associated with baseline differences between the groups in terms of the BDNF signaling pathway biomarkers, clinical or treatment variables. Conclusions These findings highlight the biological impact that a relapse produces over the systemic BDNF-TrkB signaling pathway, potentially undermining crucial neuronal functions. Identifying the actors involved can help design specific interventions for relapse prevention and improve the functional prognosis of people in the early stages of schizophrenia.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Validation of the virtual reality functional capacity assessment tool (VRFCAT) in a Spanish sample of individuals with psychosis and healthy controls

  • González-Blanch, César
  • López-Carrilero, Raquel
  • Bobes-Bascarán, Teresa
  • Catalán, Ana
  • Aymerich, Claudia
  • Rodriguez-Jimenez, Roberto
  • Gutiérrez-Zotes, Alfonso
  • Díaz-Mandado, Olimpia
  • González-Pinto, Ana
  • Cano-Escalera, Guillermo
  • Zubia, Marta
  • Guinart, Daniel
  • Del-Castillo-Serrano, Manuel
  • Vilella, Elisabet
  • García-Álvarez, Leticia
  • Ochoa, Susana
  • Correa-Ghisays, Patricia
  • Balanzá-Martínez, Vicent
  • Sánchez-Ortí, Joan Vicent
  • Pousa, Esther
  • Miret, Salvador
  • Falip, Cristina
  • Reguera-Pozuelo, Pablo
  • Fernández-Martínez, Rafael
  • García-Cabeza, Ignacio
  • Campos-Rodriguez, Carlos
  • Crosas, Josep Maria
  • Cobo, Jesus
  • Pardina-Torner, Helena
  • Perona-Garcelán, Salvador
  • Muñoz-Caracuel, Manuel
  • Yorca-Ruiz, Ángel
  • Ortiz-García de la Foz, Víctor
  • Ayesa-Arriola, Rosa
Background The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) is a performance-based measure developed to assess functional capacity through simulations of daily activities. This study examined its psychometric properties in a Spanish sample, including individuals with first-episode psychosis (FEP), schizophrenia, and healthy controls. Methods A total of 370 participants (99 FEP, 116 schizophrenia, and 155 controls) completed the VRFCAT in a multicenter study. Internal consistency (McDonald’s omega), discriminative validity (group comparisons and ROC curves), and convergent validity via correlations with cognitive performance and clinical symptoms were examined. Reference percentiles were calculated from the healthy control sample using quantile regression, stratified by age and education. Results Item-level VRFCAT completion times showed acceptable to good internal consistency overall and in controls and schizophrenia samples, but poor in FEP. Differences in VRFCAT performance emerged (χ2 = 108.88, p < .001), with controls performing best, schizophrenia worst, and FEP in between. ROC analyses indicated good discriminative accuracy in distinguishing patients from controls (area under the curve [AUC] = 0.779, sensitivity = 80.0%, specificity = 64.2%); but limited discrimination between schizophrenia and FEP. Age and education, but not sex, significantly affected performance. VRFCAT showed small-to-moderate correlations with cognitive performance, and no significant associations with symptom severity. Conclusions The VRFCAT is a reliable and valid tool for assessing functional capacity in Spanish-speaking individuals with psychotic disorders. Its ecological validity, objectivity, psychometric properties, brief administration time, and ease of use support its potential use in clinical and research settings for evaluating functional recovery and treatment outcomes., This study was supported by the Instituto de Salud Carlos III (ISCIII) through project PI20/00066, co-funded by the European Union. Ana González-Pinto acknowledges the support of the Spanish Ministry of Science, Innovation and Universities, integrated into the National R&D&I Plan and co-funded by the ISCIII–Subdirección General de Evaluación and the European Regional Development Fund (FEDER; grants PI18/01055 and PI21/00713), as well as the CIBERSAM, the Basque Government (grant 2022111054), and the University of the Basque Country (grant IT1631–22). Roberto Rodriguez-Jimenez is partially supported by the Madrid Regional Government (R&D activities in Biomedicine S2022/BMD–7216 (AGES 3–CM)), and CIBERSAM-ISCIII. Ángel Yorca-Ruiz is funded by a predoctoral contract (PFIS FI/00162) from the Carlos III Health Institute. Rosa Ayesa-Arriola was funded by a Miguel Servet contract from the Carlos III Health Institute (CP18/00003) and a Consolidator Grant from the Spanish Ministry of Science and Innovation (CNS2022–136110).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis

  • Solanes, Aleix|||0000-0002-2491-200X
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Janssen, Joost|||0000-0001-7613-2067
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Arango, Celso|||0000-0003-3382-4754
  • Vieta, Eduard|||0000-0002-0548-0053
  • Castro-Fornieles, Josefina|||0000-0003-0632-2687
  • Bergé Baquero, Daniel|||0000-0003-2544-1016
  • Albacete, Auria|||0000-0003-4156-4972
  • Giné Serven, Eloi|||0000-0002-3130-5566
  • Parellada, Mara|||0000-0001-7977-3601
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • Radua, Joaquim|||0000-0003-1240-5438
Detecting patients at high relapse risk after the first episode of psychosis (HRR-FEP) could help the clinician adjust the preventive treatment. To develop a tool to detect patients at HRR using their baseline clinical and structural MRI, we followed 227 patients with FEP for 18-24 months and applied MRIPredict. We previously optimized the MRI-based machine-learning parameters (combining unmodulated and modulated gray and white matter and using voxel-based ensemble) in two independent datasets. Patients estimated to be at HRR-FEP showed a substantially increased risk of relapse (hazard ratio = 4.58, P < 0.05). Accuracy was poorer when we only used clinical or MRI data. We thus show the potential of combining clinical and MRI data to detect which individuals are more likely to relapse, who may benefit from increased frequency of visits, and which are unlikely, who may be currently receiving unnecessary prophylactic treatments. We also provide an updated version of the MRIPredict software.